Plunging sales of Merck’s blockbuster HPV vaccine in China have caused a sharp fall in the US pharma group’s earnings.
美国制药集团默克(Merck)的重磅产品HPV疫苗在华销售额大幅下滑，导致该公司盈利大幅下滑。